Schistosomiasis

New England Journal of Medicine

Volumn 346, Issue 16, 2002, Pages 1212-1220

  Ross, Allen G P ^a   Bartley, Paul B ^b   Sleigh, Adrian C ^b   Richard Olds, G ^c   Li, Yuesheng ^b   Williams, Gail M ^b   McManus, Donald P ^b,d  

^a MEDICAL UNIVERSITY OF THE AMERICAS   (Saint Kitts and Nevis)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BILHVAX; CORTICOSTEROID; DNA VACCINE; GLUTATHIONE S TRANSFERASE 26; GLUTATHIONE TRANSFERASE; HYCANTHONE; ISOQUINOLINE DERIVATIVE; OXAMNIQUINE; PARAMYOSIN; PARASITE ANTIGEN; PRAZIQUANTEL; PYRAZINE DERIVATIVE; SCHISTOSOMA VACCINE; SJ 97; SJ GST 26; UNCLASSIFIED DRUG;

CLINICAL TRIAL; GASTROINTESTINAL DISEASE; HUMAN; INFECTION SENSITIVITY; LIFE CYCLE; LIVER DISEASE; NEUROLOGIC DISEASE; PARASITE DEVELOPMENT; PARASITE LOCALIZATION; PATHOPHYSIOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS; UROGENITAL TRACT DISEASE;

ANIMALS; ARTEMISININS; DRUG THERAPY, COMBINATION; FECES; HUMANS; LIFE CYCLE STAGES; OVUM; PRAZIQUANTEL; SCHISTOSOMA; SCHISTOSOMIASIS; SCHISTOSOMICIDES; SESQUITERPENES; VACCINES;

EID: 0037129443     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMra012396     Document Type: Review

References (83)

1. The global status of schistosomiasis and its control
2. Schistosomiasis vaccine development - The current picture
3. Reaching maturity - 25 Years of the TDR
4. Worm infections fester as experts vie for fair share of funding
5. Effects of environmental change on emerging parasitic diseases
6. Dam worms
7. The pathology of schistosome infections
8. A historical review of early Japanese contributions to the knowledge of Schistosomiasis japonica
9. Katayama fever: An acute manifestatinn of schistosomiasis
10. Pulmonary schistosomiasis
11. Acute pulmonary schistosomiasis in travelers returning from Lake Malawi, sub-Saharan Africa
12. WHO/WPRO consultant mission report
13. Progress in the assessment of morbidity due to Schistosomajaponicum infection: A review of recent literature
14. Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs
15. Initiation and regulation of disease in schistosomiasis
16. Immunological control of hepatotoxicity and parasite egg excretion in Schistosoma mansoni infections: Stage specificity of the reactivity of immune serum in T-cell deprived mice
17. The schistosome egg granuloma: Immunopathology in the cause of host protection or parasite survival
18. Studies on schistosomiasis in western Kenya. I. Evidence for immune-facilitated excretion of schistosome eggs from patients with Schistosoma mansoni and human immunodeficiency virus collections
19. Granulomatous disease of the large intestine secondary to schistosome infestation: A study of 229 cases
20. Schistosoma japonicum: Migration of adult worm pairs within the mesenteric veins of mice
21. Relative distribution of Schistosoma japonicum eggs in the intestine of man: A subject of inconsistency
22. Diagnosis of Schistosomiasis japonica in Chinese schoolchildren by administration of a questionnaire
23. Multiple endoscopic polypectomies for schistosomal polyposis of the colon
24. Inflammatory cecal masses in patients presenting with appendicitis
25. Histological classification of schistosomal egg induced polyps of colon and their clinical significance: An analysis of 272 cases
26. The surgical pathology of colorectal carcinomas in Nigerians
27. Immunity and morbidity in Schistosomiasis japonicum infection
28. A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 3. Schistosoma japonicum
29. A review of the literature on the use of ultrasonography in schistosomiasis with special reference to its use in field studies. 2. Schistosoma mansoni
30. Two-year impact ofpraziquantel for Schistosoma japonicum infection in China: Re-infection, subclinical disease and fibrosis marker measurements
31. Disease in schistosomiasis haematobia
32. Risk factors for hepatocellular carcinoma in Egypt: The role ofhepatitis-B viral infection and schistosomiasis
33. Hepatitis B and C virus markers among patients with hepatosplenic mansonic schistosomiasis
34. Absence of relationship between Schistosomajaponicum and hepatitis B virus infection in the Dongting Lake region, China
35. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt
36. Evolution of Schisrosoma haematobium-related pathology over 24 months after treatment with praziquantel among school children in southeastern Tanzania
37. Parasites in the etiology of cancer - Bilharziasis and bladder cancer
38. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt
39. Schistosomiasis and neoplasia
40. Female genital schistosomiasis: Facts and hypotheses
41. Lesions of schistosomiasis mimicking warts on the vulva
42. Female genital schistosomiasis: A neglected risk factor for the transmission of HIV?
43. Schistosomiasis in Lake Malawi
44. Schistosomiasis of the central nervous system: Experiences in World War II and a review of the literature
45. The role ofcorticosteroids in the treatment of cerebral schistosomiasis caused by Schistosoma mansoni: Case report and discussion
46. Schistosomiasis japonica and childhood nutritional status in northeastern Leyte, the Philippines: A randomized trial of praziquantel versus placebo
47. Child growth, nutritional status, and Schistosomiasis japonica in Jiangxi, People's Republic of China
48. Evidence for an improvement in cognitive function following treatment of Schistosoma japonicum infection in Chinese primary schoolchildren
49. Schistosomiasis in expatriates returning to Britain from the tropics: A controlled study
50. Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country
51. Association between HLA-A, B, C and DR antigens and clinical manifestations of Schistosoma haematobium in the bladder
52. HLA-DR-DQ alleles and HLA-DP alleles are independently associated with susceptibility to different stages of post-schistosomal hepatic fibrosis in the Chinese population
53. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene
54. Genetic control of schistosome infections by the SM1 locus of the 5q31-q33 region is linked to differentiation of type 2 helper T lymphocytes
55. Algorithms for detection and identification of parasites
56. A simple device for quantitative stool thick-smear technique in Schistosomiasis mansoni
57. Epidemiologic features of Schistosoma japonicum among fishermen and other occupational groups in the Dongting Lake region (Hunan Province) of China
58. Schistosoma mansoni-related morbidity on Ukerewe Island, Tanzania: Clinical, ultrasonographical and biochemical parameters
59. Immunodiagnosis of schistosomiasis
60. Application of immunodiagnostic assays: Detection of antibodies and circulating antigens in human schistosomiasis and correlation with clinical findings
61. Schistosomiasis in the People's Republic of China: Prospects and challenges for the 21st century
62. A rapid one-step method of EIA for detection of circulating antigen of Schistosoma japonicum
63. Serum procollagen peptides and collagen type VI for the assessment of activity and degree of hepatic fibrosis in schistosomiasis and alcoholic liver disease
64. A quantitative assay to detect circulating fibrosin and its application in experimental schistosomiasis
65. The efficacy of praziquantel against cestodes in animals
66. The chemotherapeutic effect of praziquantel against Schistosoma mansoni is dependent on host antibody response
67. Evolution of schistosomiasis-induced pathology after therapy and interruption of exposure to schistosomes: A review of ultrasonographic studies
68. Evidence for a longterm effect of a single dose of raziquantel on Schisrosoma mansoni induced hepatosplenic lesions in northern Uganda
69. Studies on schistosomiasis in western Kenya. II. Efficacy ofpraziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1
70. The effect of treatment of schistosomiasis on blood plasma HIV-1 RNA concentration in coinfected individuals
71. Field studies on the preventive effect of oral artemether against schistosomal infection
72. The prophylactic effects of artemether against Schistosoma japonicum infections
73. Oral artemether for prevention of Schistosoma mansoni infection: Randomised controlled trial
74. Effect of artemether against Schistosoma haematobium in experimentally infected hamsters
75. Effect of praziquantel together with artemether on Schistosoma japonicum parasites of different ages in rabbits
76. Anti-schistosomal drugs: Observations on the mechanism of resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel
77. Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections
78. Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers
79. Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya
80. The search for a vaccine against schistosomiasis - A difficult path but an achievable goal
81. Vaccine strategies against schistosomiasis: From concepts to clinical trials
82. Schistosomiasis vaccines: A response to a devil's advocate's view